Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients

BACKGROUND: A substantial proportion of critically ill COVID-19 patients develop thromboembolic complications, but it is unclear whether higher doses of thromboprophylaxis are associated with lower mortality rates. The purpose of the study was to evaluate the association between initial dosing strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonmarker, Sandra, Hollenberg, Jacob, Dahlberg, Martin, Stackelberg, Otto, Litorell, Jacob, Everhov, Åsa H., Järnbert-Pettersson, Hans, Söderberg, Mårten, Grip, Jonathan, Schandl, Anna, Günther, Mattias, Cronhjort, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680989/
https://www.ncbi.nlm.nih.gov/pubmed/33225952
http://dx.doi.org/10.1186/s13054-020-03375-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680989/
https://www.ncbi.nlm.nih.gov/pubmed/33225952
http://dx.doi.org/10.1186/s13054-020-03375-7

Ejemplares similares